EGFR and K-ras mutations in cytologic samples from fine-needle aspirates in NSCLC patients.

1 Bush A, Hedlin G, Carlsen KH, et al. Severe childhood asthma: a common international approach? Lancet 2008; 372: 1019–1021. 2 Hedlin G, Bush A, Lødrup Carlsen K, et al. Problematic severe asthma in children, not one problem but many: a GALEN initiative. Eur Respir J 2010; 36: 196–201. 3 Lang AM, Konradsen J, Carlsen KH, et al. Identifying problematic severe asthma in the individual child – does lung function matter? Acta Paediatr 2010; 99: 404–410. 4 Payne D, Bush A. Phenotype-specific treatment of difficult asthma in children. Paediatr Respir Rev 2004; 5: 116–123. 5 Lødrup Carlsen KC, Hedlin G, Bush A, et al. Assessment of problematic severe asthma in children. Eur Respir J 2011; 37: 432–440. 6 Bracken M, Fleming L, Hall P, et al. The importance of nurse-led home visits in the assessment of children with problematic asthma. Arch Dis Child 2009; 94: 780–784. 7 Bush A, Saglani S. Management of severe asthma in children. Lancet 2010; 376: 814–825. 8 Marinho S, Simpson A, Soderstrom L, et al. Quantification of atopy and the probability of rhinitis in preschool children: a populationbased birth cohort study. Allergy 2007; 62: 1379–1386. 9 Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59–65. 10 Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J 1996; 9: 636–642.